Guadalupe
Hayes-Mota
Advocate for patients to have access to medicines and health services globally
Healthcare, Biotech, & Public Service Leader:
Story
Born in Mexico with a rare and debilitating bleeding disorder, Guadalupe nearly died at twelve because of limited access to medicines. One night, his appendix burst, and he began bleeding internally, requiring emergency surgery. In search of better medication to stop the bleeding, Guadalupe was rushed to a hospital eight hours away. He bled so severely during the surgery that his heart stopped beating, and the doctors declared him clinically dead. But against all odds, Guadalupe survived.
After his recovery, his family and he migrated to the U.S., searching for better healthcare for him. The transition was difficult: his parents arrived in California with little money or education, and Guadalupe spoke no English. Navigating the health care system as an immigrant and not knowing the language was a challenge. Accessing treatment and services for his disease was practically impossible at first. The nearest specialist was one hr and a half away. Thankfully, he gained access to care and treatment with help from the Hemophilia Association chapter in the area. Driven by his experiences, Guadalupe made it his mission to fight for justice and equity in the healthcare system.
Guadalupe Hayes-Mota
Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.
Experience
Mission..............................
Guadalupe envisions a world where medical care isn't a privilege, but a right. Drawing strength from his own life on the fringes, he stands for justice and equity. He's not just a voice, but a driving force, igniting change and innovation across healthcare, from biopharmaceuticals to non-profits.
Professional Experience.........
Drawing from vast healthcare expertise, Guadalupe is a serial entrepreneur. Currently, he is the CEO & Co-Founder of a Stealth AI Healthcare Startup. He is a writer for Forbes and Fast Company in biotechnology, AI, and business and teaches at MIT as a faculty member (Senior Lecturer). Previously, Guadalupe founded and led as CEO of Healr Solutions, a tech pioneer addressing critical biopharmaceutical supply chain challenges, impacting 43 countries. Venture got acquired by major investors. He's steered global divisions of powerhouse firms like Ultragenyx, Biogen, Amgen, and GSK as Senior Vice-President and Chief Supply Chain Officer, and he ensured medicine reached 2.3 billion people across 113 countries.
Under his leadership, UCLA Health became the largest free healthcare provider in the U.S., serving 30,000 underserved individuals. A key contributor to the Affordable Care Act, he helped extend healthcare to 20 million Americans while at the RAND Corporation. Beyond boardrooms, Guadalupe has also collaborated on groundbreaking drug research at MIT with Moderna's founder, Professor Bob Langer.
Public Service & Boards.........
The US Secretary of Health and Human Services, Xavier Becerra appointed Hayes-Mota to serve on the National Institutes of Health (NIH)'s Cures Acceleration Network Review Board to help accelerate the development of treatments for patients
Appointed by Governor Charlie Baker to the Massachusetts Rare Disease Advisory Council, Guadalupe shapes state policy on rare diseases, guiding key decision-makers from the governor's office to the public health department.
He is an AI Expert Advisor to the European Commission, providing guidance for AI policy for the EU.
A recognized healthcare authority, he's been featured in high-profile outlets such as Forbes, Inc., Fast Company, MarketWatch, Boston Globe, MIT Technology Review and has delivered keynotes at the National Academy of Engineering, MIT, Harvard, and UPenn, even testifying before the U.S. Congress.
Guadalupe Hayes-Mota has extensive expertise and has held leadership positions on boards of directors and advisory boards, serving in roles ranging from chairman of the board to treasurer. He has sat on multiple boards including AI 2030, Blue Clay Health, Save One Life, MIT Alumni Association, and Fenway Health. He serves as an Advisory Board Member for Sanofi, a Fortune 500 biopharmaceutical, a Forbes Business Council Member, a Fast Company Impact Council Member, and a Harvard Business Review Advisory Council Member
Education............................
Guadalupe received a BS in Chemistry, BS in Literature, an MS in AI Engineering Systems, and an MBA from MIT. He obtained a Master of Public Policy from Georgetown University, and a Master of Public Administration from Harvard University. He is a current candidate for a Doctor of Engineering in Artificial Intelligence (AI) and Machine Learning (ML) at The George Washington University.
Honors................................
-
6 Powerful LGBTQ+ Executives - Business Insider
-
US Young Engineering Leader - National Academy of Engineering
-
John F. Kennedy Fellowship - Harvard University
-
Notable Alum - MIT
-
100 Top Leaders in the Life Science Industry - PharmaVoice
-
40 under 40 - Boston Business Journal
-
Healthcare Executive of the Year - Los Angeles Business Journal
Public Service
Fenway Health
Finance Committee Chair,
Board of Directors
Delivers inclusive health care and support to LGBTQIA+, BIPOC, and underserved groups, focusing on transformative research and education for global impact
Rare Disease Advisory Council
Council Member
Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in Massachusetts
Save One Life
Strategic Committee Chair,
Board of Directors
Empowers individuals and families affected by bleeding disorders in developing countries through direct financial assistance and access to medical treatment.
MIT Alumni Association
Board of Directors
Empower MIT alumni to contribute to a better world, fostering mutual engagement and support within the global MIT community